Electra Therapeutics (ETRA)
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel ta...
- Open
- 11.140
- High
- 11.575
- Low
- 10.460
- Prev. Close
- 11.250
- Volume
- 1.26M
- Turnover
- 13.57M
- Avg Price
- 10.812
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 9.91%
- 52wk High
- 15.500
- Volume Ratio
- 0.00
- Turnover Ratio
- 4.20%
- 52wk Low
- 10.460
- Float Mkt Cap
- 319.44M
- Market CapUSD
- 670.35M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.52
- EPSDynamic
- -1.87
- EPSStatic
- --
- BVPS
- -3.50
- P/B
- --
- Circulating Supply
- 29.91M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 62.77M
- Min lot size
- 1
- Currency
- USD
News
- benzinga_article · 1 day ago, 12:05 PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- TradingView · Sep 25 at 09:36 PM
OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake
- PUBT · Sep 23 at 09:30 PM
OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million
- PUBT · Sep 22 at 01:01 AM
Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership
- PUBT · Sep 21 at 08:01 PM
Electra Therapeutics adopts amended, restated bylaws effective at IPO close
- PUBT · Sep 21 at 04:45 AM
HBM Healthcare Investments says Electra Therapeutics IPO raises USD 350 million
